Search
for
Sort by
Research 30 of 464
- Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Acneiform Eruption with Topical Recombinant Human Epidermal Growth Factor
- Vellus hair cysts presenting as an atypical acneiform eruption
- Acne and acneiform eruptions
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839
- BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata
- Sorafenib-induced Facial Acneiform Eruption
- Acneform eruptions with use of minoxidil-a case report
- Erlotinib induced acneiform eruption: A case report
- Sorafenib-Associated Facial Acneiform Eruption
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Cyclophosphamide-associated acneiform drug eruption in a patient with multiple myeloma
- A Sterile Folliculocentric Acneiform Eruption Mimicking Infection After Hair Transplantation: Clinical Pattern Recognition and a Proposed FUE Epidermal Cap–Angle Mechanism
- Chronic cutaneous lupus erythematosus presenting as atypical acneiform and comedonal plaque: case report and literature review
- When bugs and drugs conspire: driving acneiform skin toxicity
- Pustular Eruption in a Patient Treated With Trametinib
- Severe Pustular Drug Eruptions From Amivantamab: A Case Series
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- Drug-Induced Skin, Nail and Hair Disorders
- Drug-induced acne
- Dermatological side effects of epidermal growth factor receptor inhibitors: ′Pride′ complex
- Cutaneous side-effects of EGFR inhibitors and their management.
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Mucocutaneous manifestations of acquired hypoparathyroidism: An observational study
- Difficult and rare forms of acne
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Cutaneous Toxicities From Transplantation-Related Medications